drawing of head and brain with NI logo
faculty in a lab setting

Addictions

Innovative and integrated neuroscience curriculum

faculty member with lab equipment

Neuro Trauma

Cutting-edge research in spinal cord injury

Main Content

UMMC Neuro Institute

The UMMC Neuro Institute is a multi-department, multi-institution collaborative with a mission to integrate high quality health care, ground-breaking research, and innovative educational programs within the field of neuroscience.

UMMC’s strength as an academic medical center makes it an ideal location to pursue collaborative and translational projects. The institute complements and builds upon existing areas of strength in neuroscience to discover new cures and develop improved treatments.

Established in 2016, we aim to:

  • Build partnerships among departments, schools and hospitals based on a model of shared governance, and working together across traditional boundaries;
  • Serve as an "open umbrella" to bring people, departments and organizations together to address major public health issues related to the brain and nervous system;
  • Focus on developing selected areas of excellence and opportunity, each integrating all three domains of health care, research and education.

Our members include researchers, educators, physicians and other health care providers in the departments of Advanced Biomedical Education, Neurology, Psychiatry and Human Behavior, and Neurosurgery at UMMC, as well as the Methodist Rehabilitation Center.

Neuroscience is a broad field that encompasses all diseases of the nervous system. The Neuro Institute’s three focal points – addiction, neurotrauma and stroke –  represent areas of opportunity for integration and growth of health care, research and education.

Featured News

Esketamine, a new treatment for the severely depressed, is being hailed as a game-changer by researchers.

UMMC researcher’s pioneering work gives rise to new severe depression drug

Thursday, March 21, 2019

Thirty years ago, Dr. Ian Paul and a group of fellow young researchers had a hypothesis: that major depression has a connection with the brain neurotransmitter glutamate, and that drugs that block glutamate receptors would have an anti-depressive effect. It proved true, making possible the highly acclaimed drug esketamine, the first truly new depression treatment in three decades. Read More

Addiction psychiatrist expanding treatment for opioid use disorder

Addiction psychiatrist expanding treatment for opioid use disorder

Thursday, October 11, 2018

UMMC’s addiction program has reached a milestone. New faculty member Dr. Saurabh Bhardwaj, an addiction psychiatrist, is the Medical Center’s first provider to offer medication-assisted treatment, or MAT, for those coping with opioid use disorder. Read More

Latest News

Esketamine, a new treatment for the severely depressed, is being hailed as a game-changer by researchers.

UMMC researcher’s pioneering work gives rise to new severe depression drug

Published on Thursday, March 21, 2019

Addiction psychiatrist expanding treatment for opioid use disorder

Addiction psychiatrist expanding treatment for opioid use disorder

Published on Thursday, October 11, 2018

Among the several UMMC faculty using elastin-like polypeptides to study new ways to treat disease are, from left, Dr. Lee Bidwell, Dr. Alejandro Chade, Dr. Drazen Raucher, Dr. Eric George, Dr. Amol Janorkar and Dr. Parminder Vig.

Medical Center among ELP research, patent leaders

Published on Monday, October 1, 2018

Dr. Loretta Jackson-Williams, professor of medicine and vice dean for medical education, helps first-year medical student Anna Margaret McDonnell slip into her coat during the Aug. 9 White Coat Ceremony.

A class apart: Medical school breaks admissions record

Published on Monday, September 17, 2018

Lacking concussion system, Mississippi athletes in contact sports at risk

Lacking concussion system, Mississippi athletes in contact sports at risk

Published on Thursday, August 30, 2018

Tyler Luchtefeld, a physical therapy resident, affixes a device to soccer player Cameron Allcorn's head to test reflexes and motor skills.

Clinical trial explores physical therapy for sports-related concussion, leg injury prevention

Published on Monday, August 20, 2018

UMMC Grenada offers first-time inpatient substance abuse detox program

UMMC Grenada offers first-time inpatient substance abuse detox program

Published on Monday, July 30, 2018

New School of Medicine graduate Claire Harkey celebrates with her father, Dr. Louis Harkey, immediately after being hooded by him.

Class of 2018 is family friendly

Published on Thursday, May 31, 2018

stethoscope on top of laptop

StrokeNet Partnership

The Neuro Institute will be a partner site with the University of Alabama at Birmingham’s StrokeBelt/StrokeNet initiative. As part of the partnership, NI agreed to maintain a screening log of stroke patients and communicate this information throughout the network to enhance clinical research trial screenings, enrollment and retention.

MORE
researcher and participant

Neuroscience Grant

The Neuro Institute in conjunction with the Office of Research offers a Pilot Research Grant Program to support development of innovative, cutting-edge research across the spectrum of basic, translational, clinical and population-based neuroscience, and facilitate development of collaborative teams of scientists, clinicians and other health care professionals from multiple departments, schools and disciplines.

MORE
group of providers

Program in Neuroscience

The Program in Neuroscience is an interdepartmental PhD degree program with faculty from basic science and clinical departments. Our small, diverse student population comes from across the country. Over the past 4 years, Our students have authored 40 first-author papers on their way to earning a PhD. Students go on to academic post-doc fellowships at academic institutions.

MORE